{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:04:27Z","timestamp":1791295467645,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003458","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T15:49:05Z","timestamp":1373989745000},"page":"e1003458","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["Dissection of Antibody Specificities Induced by Yellow Fever Vaccination"],"prefix":"10.1371","volume":"9","author":[{"given":"Oksana","family":"Vratskikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Stiasny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Zlatkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsouchnikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Jarmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Karrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roggendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedwig","family":"Roggendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Allwinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz X.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,6,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"AD Barrett","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"ref2","unstructured":"Monath TP, Gershman M, Staples JE, Barrett AD (2012) Yellow fever vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines: Saunders Elsevier. pp. 870\u2013968."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"TD Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"B Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D","volume":"590","author":"TD Querec","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"ref6","unstructured":"Simmonds P, Becher P, Collett MS, Gould EA, Heinz FX, <etal>et al<\/etal>.. (2011) Family Flaviviridae. In: King AMQ, Lefkowitz E, Adams MJ, Carstens EB, editors. Virus Taxonomy IXth Report of the International Committee on Taxonomy of Viruses. San Diego: Elsevier Academic Press."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2010.09.005","article-title":"Molecular mechanisms involved in the early steps of flavivirus cell entry","volume":"13","author":"B Kaufmann","year":"2011","journal-title":"Microbes Infect"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcv.2012.08.024","article-title":"Flaviviruses and their antigenic structure","volume":"55","author":"FX Heinz","year":"2012","journal-title":"J Clin Virol"},{"key":"ref9","unstructured":"Lindenbach BD, Thiel HJ, Rice CM (2007) Flaviviridae: The viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA <etal>et al<\/etal>.., editors. Fields Virology. 5 ed. Philadelphia: Lippincott. Williams &amp; Wilkins. pp. 1101\u20131152."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/JVI.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"K Stadler","year":"1997","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1089316","article-title":"Structure of West Nile virus","volume":"302","author":"S Mukhopadhyay","year":"2003","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"RJ Kuhn","year":"2002","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00726-009-0370-4","article-title":"Molecular mechanisms of flavivirus membrane fusion","volume":"41","author":"K Stiasny","year":"2011","journal-title":"Amino Acids"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"W Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"M Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.coviro.2012.02.011","article-title":"Degrees of maturity: the complex structure and biology of flaviviruses","volume":"2","author":"TC Pierson","year":"2012","journal-title":"Curr Opin Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"TC Pierson","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"K Stiasny","year":"2006","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"WD Crill","year":"2004","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1128\/JVI.05859-11","article-title":"Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms","volume":"85","author":"MR Vogt","year":"2011","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COH.0b013e32832e06fe","article-title":"Specificities of broadly neutralizing anti-HIV-1 sera","volume":"4","author":"J Binley","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/JVI.01992-08","article-title":"Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals","volume":"83","author":"Y Li","year":"2009","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/eji.200839129","article-title":"Clonal dissection of the human memory B-cell repertoire following infection and vaccination","volume":"39","author":"D Pinna","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.2010.05829.x","article-title":"Structural basis of influenza virus neutralization","volume":"1217","author":"T Han","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro1819","article-title":"The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus","volume":"6","author":"GB Karlsson Hedestam","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e4991","DOI":"10.1371\/journal.pone.0004991","article-title":"Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens","volume":"4","author":"WD Crill","year":"2009","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1128\/JVI.00643-07","article-title":"Induction of epitope-specific neutralizing antibodies against West Nile virus","volume":"81","author":"T Oliphant","year":"2007","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II","volume":"82","author":"CY Lai","year":"2008","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-3527(08)60263-8","article-title":"Epitope mapping of flavivirus glycoproteins","volume":"31","author":"FX Heinz","year":"1986","journal-title":"Adv Virus Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0042-6822(84)90422-7","article-title":"Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein","volume":"133","author":"FX Heinz","year":"1984","journal-title":"Virology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9177","DOI":"10.1128\/JVI.75.19.9177-9186.2001","article-title":"Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6","volume":"75","author":"F Verrier","year":"2001","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1073\/pnas.0903427106","article-title":"Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines","volume":"106","author":"W Ndifon","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"SM Lok","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1002111","DOI":"10.1371\/journal.ppat.1002111","article-title":"A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus","volume":"7","author":"KA Dowd","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.str.2012.01.001","article-title":"Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody","volume":"20","author":"JJ Cockburn","year":"2012","journal-title":"Structure"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.str.2012.01.014","article-title":"Capturing a Virus while It Catches Its Breath","volume":"20","author":"TC Pierson","year":"2012","journal-title":"Structure"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.4049\/jimmunol.1200227","article-title":"Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity","volume":"188","author":"CM Midgley","year":"2012","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e1002930","DOI":"10.1371\/journal.ppat.1002930","article-title":"Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope","volume":"8","author":"SK Austin","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e1000821","DOI":"10.1371\/journal.ppat.1000821","article-title":"Natural strain variation and antibody neutralization of dengue serotype 3 viruses","volume":"6","author":"WM Wahala","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2","volume":"84","author":"S Sukupolvi-Petty","year":"2010","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1128\/JVI.01190-10","article-title":"Genotype-specific neutralization and protection by antibodies against dengue virus type 3","volume":"84","author":"JD Brien","year":"2010","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e1000060","DOI":"10.1371\/journal.ppat.1000060","article-title":"Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization","volume":"4","author":"S Nelson","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virol.2005.04.031","article-title":"Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants","volume":"337","author":"S Daffis","year":"2005","journal-title":"Virology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354","volume":"107","author":"B Kaufmann","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus","volume":"80","author":"M Throsby","year":"2006","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/JVI.00286-09","article-title":"Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step","volume":"83","author":"MR Vogt","year":"2009","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1128\/JVI.78.23.12919-12928.2004","article-title":"Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein","volume":"78","author":"AP Goncalvez","year":"2004","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"R de Alwis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/JVI.01886-10","article-title":"Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice","volume":"85","author":"J Zlatkovic","year":"2011","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The human antibody response to dengue virus infection","volume":"3","author":"WM Wahala","year":"2011","journal-title":"Viruses"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1128\/JVI.06871-11","article-title":"Recombinant dengue type 2 viruses with altered e protein domain III epitopes are efficiently neutralized by human immune sera","volume":"86","author":"WM Wahala","year":"2012","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","article-title":"Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody","volume":"392","author":"WM Wahala","year":"2009","journal-title":"Virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4049\/jimmunol.98.4.673","article-title":"Heterotypic serologic responses after yellow fever vaccination; detection of persons with past St. Louis encephalitis or dengue","volume":"98","author":"WL Pond","year":"1967","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jmv.1890170106","article-title":"Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine","volume":"17","author":"M Kayser","year":"1985","journal-title":"J Med Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"MV Cherrier","year":"2009","journal-title":"EMBO J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2180-2-9","article-title":"Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses","volume":"2","author":"MJ Cardosa","year":"2002","journal-title":"BMC Microbiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e1188","DOI":"10.1371\/journal.pntd.0001188","article-title":"In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection","volume":"5","author":"R de Alwis","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nrmicro2893","article-title":"Structural vaccinology starts to deliver","volume":"10","author":"PR Dormitzer","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/0022-1317-57-2-263","article-title":"Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses","volume":"57","author":"FX Heinz","year":"1981","journal-title":"J Gen Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4269\/ajtmh.1958.7.561","article-title":"Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses","volume":"7","author":"DH Clarke","year":"1958","journal-title":"Am J Trop Med Hyg"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"L Li","year":"2008","journal-title":"Science"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T02:48:50Z","timestamp":1688352530000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003458"}},"subtitle":[],"editor":[{"given":"Ted C.","family":"Pierson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003458","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,20]]}}}